Table 5.

Bevacizumab and dimer content, expressed as a percentage, for each biosimilar product.

	Bevacizumab (%)			Dimer (%)
Product	Mean	Sigma	Min–Max	Mean	Sigma	Min–Max
Biosimilar #1	98.72	0.259	98.36–99.12	1.405	0.242	1.145–1.780
Biosimilar #2	99.22	0.220	98.99–99.56	0.808	0.176	0.630–1.048
Biosimilar #3	98.17	0.270	97.84–98.52	2.083	0.195	1.808–2.356